324 related articles for article (PubMed ID: 17927689)
21. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells.
Hu J; Nakano H; Sakurai H; Colburn NH
Carcinogenesis; 2004 Oct; 25(10):1991-2003. PubMed ID: 15192014
[TBL] [Abstract][Full Text] [Related]
22. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.
Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N
Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760
[TBL] [Abstract][Full Text] [Related]
23. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
[TBL] [Abstract][Full Text] [Related]
24. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
25. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity.
Jobin C; Bradham CA; Russo MP; Juma B; Narula AS; Brenner DA; Sartor RB
J Immunol; 1999 Sep; 163(6):3474-83. PubMed ID: 10477620
[TBL] [Abstract][Full Text] [Related]
26. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
27. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
Hoberg JE; Popko AE; Ramsey CS; Mayo MW
Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
[TBL] [Abstract][Full Text] [Related]
28. Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.
Cook JL; Walker TA; Worthen GS; Radke JR
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9966-71. PubMed ID: 12119420
[TBL] [Abstract][Full Text] [Related]
29. Effect of NF-kappa B Inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes.
Bergmann MW; Loser P; Dietz R; von Harsdorf R
J Mol Cell Cardiol; 2001 Jun; 33(6):1223-32. PubMed ID: 11444925
[TBL] [Abstract][Full Text] [Related]
30. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.
Marquardt JU; Gomez-Quiroz L; Arreguin Camacho LO; Pinna F; Lee YH; Kitade M; Domínguez MP; Castven D; Breuhahn K; Conner EA; Galle PR; Andersen JB; Factor VM; Thorgeirsson SS
J Hepatol; 2015 Sep; 63(3):661-9. PubMed ID: 25937435
[TBL] [Abstract][Full Text] [Related]
31. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
32. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
33. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
Qiao Q; Jiang Y; Li G
Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Adam E; Quivy V; Bex F; Chariot A; Collette Y; Vanhulle C; Schoonbroodt S; Goffin V; Nguyên TL; Gloire G; Carrard G; Friguet B; De Launoit Y; Burny A; Bours V; Piette J; Van Lint C
Mol Cell Biol; 2003 Sep; 23(17):6200-9. PubMed ID: 12917341
[TBL] [Abstract][Full Text] [Related]
35. Contribution of disruption of the nuclear factor-kappaB pathway to induction of apoptosis in human leukemia cells by histone deacetylase inhibitors and flavopiridol.
Gao N; Dai Y; Rahmani M; Dent P; Grant S
Mol Pharmacol; 2004 Oct; 66(4):956-63. PubMed ID: 15235103
[TBL] [Abstract][Full Text] [Related]
36. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
Dai Y; Rahmani M; Dent P; Grant S
Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
[TBL] [Abstract][Full Text] [Related]
37. Involvement of HDAC1 and the PI3K/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin.
Kim YK; Seo DW; Kang DW; Lee HY; Han JW; Kim SN
Biochem Biophys Res Commun; 2006 Sep; 347(4):1088-93. PubMed ID: 16870149
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK.
Liu GH; Qu J; Shen X
Biochim Biophys Acta; 2008 May; 1783(5):713-27. PubMed ID: 18241676
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
40. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
Place RF; Noonan EJ; Giardina C
Biochem Pharmacol; 2005 Aug; 70(3):394-406. PubMed ID: 15950952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
